May 19, 2010
Under the Affordable Medicines Facility – malaria (AMFm), the price to buyers of artemisinin-combination therapies (ACTs) will be dropped to only US $0.05 per course through a combination of negotiations to lower prices from manufacturers and co-payments to manufacturers on behalf of buyers.
